Gargiulo, G., Esposito, G., Avvedimento, M., Nagler, M., Minuz, P., Campo, G., . . . Valgimigli, M. (2020). Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial. Circulation (New York, N.Y.), 142(5), 441. https://doi.org/10.1161/CIRCULATIONAHA.120.046928
Citace podle Chicago (17th ed.)Gargiulo, Giuseppe, et al. "Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial." Circulation (New York, N.Y.) 142, no. 5 (2020): 441. https://doi.org/10.1161/CIRCULATIONAHA.120.046928.
Citace podle MLA (9th ed.)Gargiulo, Giuseppe, et al. "Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial." Circulation (New York, N.Y.), vol. 142, no. 5, 2020, p. 441, https://doi.org/10.1161/CIRCULATIONAHA.120.046928.